- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financial Sector
Global Pharmaceuticals & Biotech Financial Sector
UPDATED Mar 25, 2024
All the companies in the financial sector, including banks, mortgage and thrifts, capital markets, consumer finance and diversified financial services.
816 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
WAT | US$342.72 | -1.3% | 13.2% | US$20.6b | US$323.50 | PE31.6x | E6.5% | n/a | ||
ALNY | US$152.07 | 3.2% | -20.2% | US$18.5b | US$220.76 | PS10.5x | E60.8% | n/a | ||
RPRX | US$30.28 | 0.8% | -19.0% | US$18.1b | US$45.40 | PE11.9x | E5.9% | 2.8% | ||
AVTR | US$25.04 | -1.7% | 18.7% | US$17.7b | US$27.20 | PE52.9x | E27.3% | n/a | ||
BMRN | US$86.52 | 3.2% | -5.4% | US$16.1b | US$109.83 | PE97.4x | E30.7% | n/a | ||
BGNE | US$153.92 | -8.7% | -31.5% | US$15.9b | US$271.02 | PS6.5x | E57.4% | n/a | ||
TEVA | US$14.06 | 5.6% | 61.1% | US$15.6b | US$15.15 | PB2.1x | E47.3% | 0% | ||
NBIX | US$140.25 | 0.6% | 44.5% | US$14.1b | US$151.79 | PE55.9x | E26.5% | n/a | ||
VTRS | US$11.83 | 0.6% | 24.9% | US$14.1b | US$12.17 | PE256.8x | E16.0% | 4.1% | ||
CRL | US$265.61 | 1.3% | 34.5% | US$14.0b | US$262.13 | PE28.7x | E11.4% | n/a | ||
BRKR | US$93.07 | 1.1% | 21.8% | US$12.9b | US$86.00 | PE30x | E8.4% | 0.2% | ||
INCY | US$57.48 | 0.2% | -18.8% | US$12.8b | US$76.01 | PE21.6x | E20.1% | n/a | ||
RVTY | US$103.00 | -1.1% | -19.5% | US$12.8b | US$123.11 | PE70.9x | E24.1% | 0.3% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
MEDP | US$402.27 | 2.9% | 119.5% | US$12.6b | US$389.50 | PE43.8x | E14.6% | n/a | ||
SRPT | US$127.94 | 3.2% | -2.4% | US$12.0b | US$164.33 | PS9.7x | E41.9% | n/a | ||
EXAS | US$63.76 | 8.3% | -4.6% | US$11.3b | US$88.49 | PS4.6x | E61.5% | n/a | ||
TECH | US$69.22 | -3.7% | -5.7% | US$11.2b | US$80.32 | PE48.6x | E9.9% | 0.5% | ||
UTHR | US$244.26 | 4.4% | 12.0% | US$11.2b | US$287.02 | PE11.7x | E7.6% | n/a | ||
NTRA | US$91.39 | 1.4% | 63.2% | US$11.1b | US$94.82 | PS10.2x | E70.6% | n/a | ||
RGEN | US$184.88 | -4.8% | 10.7% | US$11.0b | US$211.28 | PE248x | E37.6% | n/a | ||
LEGN | US$56.66 | -12.4% | 20.6% | US$10.6b | US$86.74 | PS36.1x | E62.1% | n/a | ||
CTLT | US$56.40 | 0.8% | -16.5% | US$10.1b | US$63.50 | PS2.5x | E94.0% | n/a | ||
BIO | US$341.11 | 2.3% | -27.5% | US$9.9b | US$435.73 | PS3.6x | E81.3% | n/a |